Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.
2018
A-329-18
Resolved (Interlocutory)
Biosimilars
Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)
Counsel to:
Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd., Celltrion Inc. and Pfizer Canada Inc.
The decision is reported
here.
Meet the team
Warren Sprigings
Partner
Mary McMillan
Counsel